Patient Guide: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK-001/ENGOT-ov43/GOG-3036)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 227 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT03740165
Status: ACTIVE_NOT_RECRUITING
Condition: Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms
Phase: PHASE3

Find a Study Location Near You

This study is available at 227 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Birmingham, Alabama
  • Tucson, Arizona
  • Burbank, California
  • • And 224 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily